How Long Do Patients Stay on Spravato?
Spravato (esketamine) is an FDA-approved treatment for treatment-resistant depression (TRD), but the duration of use depends on each patient’s response and progress. Some continue for months under supervision, while others may transition off sooner. At MDDCare, we guide you to expert clinics offering safe, advanced depression care so you know what to expect at every stage.
